Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4791347
Max Phase: Preclinical
Molecular Formula: C28H29N3O6S
Molecular Weight: 535.62
Molecule Type: Unknown
Associated Items:
ID: ALA4791347
Max Phase: Preclinical
Molecular Formula: C28H29N3O6S
Molecular Weight: 535.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C1C[C@]23C=C(Sc4ncccn4)C(=O)[C@@](C)(CCC(=O)Nc4c(O)ccc(C(=O)O)c4O)[C@@H]2C[C@H]1CC3
Standard InChI: InChI=1S/C28H29N3O6S/c1-15-13-28-9-6-16(15)12-20(28)27(2,24(35)19(14-28)38-26-29-10-3-11-30-26)8-7-21(33)31-22-18(32)5-4-17(23(22)34)25(36)37/h3-5,10-11,14,16,20,32,34H,1,6-9,12-13H2,2H3,(H,31,33)(H,36,37)/t16-,20+,27+,28-/m1/s1
Standard InChI Key: VMUQDCFNURPTCI-RSSVAIOBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 535.62 | Molecular Weight (Monoisotopic): 535.1777 | AlogP: 4.93 | #Rotatable Bonds: 7 |
Polar Surface Area: 149.71 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.04 | CX Basic pKa: 2.19 | CX LogP: 4.47 | CX LogD: 1.38 |
Aromatic Rings: 2 | Heavy Atoms: 38 | QED Weighted: 0.22 | Np Likeness Score: 1.22 |
1. Li Y,Weng X,Deng Y,Pan J,Zhu S,Wen Z,Yuan Y,Li S,Shen B,Duan Y,Huang Y. (2021) Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA., 12 (3.0): [PMID:33738071] [10.1021/acsmedchemlett.0c00653] |
Source(1):